What is the evidence and efficacy of the new endometriosis blood test?
This review finds that current evidence for the new endometriosis blood test is limited and indirect, indicating it may support diagnosis but cannot replace traditional methods.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This review assesses the current evidence and diagnostic efficacy of emerging blood-based biomarkers for endometriosis. The authors note that available data are limited and indirect, showing inconsistent performance metrics across different studies. Consequently, while these blood tests may offer supportive value in the diagnostic workflow, they do not currently replace traditional clinical methods such as laparoscopy. This paper is centrally about endometriosis — specifically evaluating the validity and utility of a new blood test for its diagnosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
538 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- openalex
- last seen: 2026-10-07T06:01:52.021920+00:00